Charles Schwab Investment Management Inc Regulus Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 178,879 shares of RGLS stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,879
Previous 178,879
-0.0%
Holding current value
$1.41 Million
Previous $282,000
10.99%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
79Shares Held
53.7MCall Options Held
104KPut Options Held
4.1K-
Federated Hermes, Inc. Pittsburgh, PA15.8MShares$125 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$51 Million1.07% of portfolio
-
Octagon Capital Advisors LP New York, NY4.64MShares$36.6 Million2.7% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$31.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$31.2 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $115M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...